News and Views


Nature Medicine 13, 1144 - 1145 (2007)
doi:10.1038/nm1007-1144

Where lies the blame for resistance—tumor or host?

Charles L Sawyers1

  1. Charles L. Sawyers is in the Human Oncology and Pathogenesis Program at the Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. e-mail: sawyersc@mskcc.org


Cytokine signaling from the tumor microenvironment can allow leukemia cells to survive targeted imatinib therapy, in the first report of a non-autonomous resistance mechanism.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Medicine

Subscribe

Search PubMed for

Open Innovation Challenges

naturejobs

ADVERTISEMENT